As the year barrels toward its finish, pharmaceutical marketers and medical affairs teams find themselves faced with familiar decision: how to allocate their remaining budget for maximum impact. The stakes are high, with these final moves shaping the success of the year ahead.
To cut through the noise, we’ve dug into EMJ’s data and enlisted the help of a digital experience expert to pinpoint where pharma leaders should focus their remaining spend, all based on 2024’s defining trends.
Tuesday, 6 Oct 2026
Monday, 5 Oct 2026
Tuesday, 29 Sep 2026
